Product Images Gemcitabine
View Photos of Packaging, Labels & Appearance
- fbfd32c8 27e6 4f09 a09c 5fce401b87c1 01
- fbfd32c8 27e6 4f09 a09c 5fce401b87c1 02
- fbfd32c8 27e6 4f09 a09c 5fce401b87c1 03
- fbfd32c8 27e6 4f09 a09c 5fce401b87c1 04
- fbfd32c8 27e6 4f09 a09c 5fce401b87c1 05
- fbfd32c8 27e6 4f09 a09c 5fce401b87c1 06
- fbfd32c8 27e6 4f09 a09c 5fce401b87c1 07
- fbfd32c8 27e6 4f09 a09c 5fce401b87c1 08
- fbfd32c8 27e6 4f09 a09c 5fce401b87c1 09
- fbfd32c8 27e6 4f09 a09c 5fce401b87c1 10
- fbfd32c8 27e6 4f09 a09c 5fce401b87c1 11
- fbfd32c8 27e6 4f09 a09c 5fce401b87c1 12
- fbfd32c8 27e6 4f09 a09c 5fce401b87c1 442 1
Product Label Images
The following 13 images provide visual information about the product associated with Gemcitabine NDC 50742-496 by Ingenus Pharmaceuticals, Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
fbfd32c8 27e6 4f09 a09c 5fce401b87c1 02

Progression-Free Probability and Median Gemcitabine / Carboplatin are mentioned in the text. The text also includes a Log rank value and the number of participants for each treatment. Additionally, there is a timeline for Progression-Free Survival in months.*
fbfd32c8 27e6 4f09 a09c 5fce401b87c1 05

This text appears to be a table showing the fraction surviving at different points in time, as well as the survival time (in months) for two different treatments (5-FU and Gemcitabine). The table starts with the fraction surviving at 1.0 and decreases to 0.1 in increments of 0.1, followed by 0.0. The survival time is given as 8 months for 5-FU and 12 months for Gemcitabine.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.